About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,256 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,256 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5341-5360 of 8,256 trials

CompletedSafety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress DisorderTo evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.NCT04044664·Tuscaloosa, Alabama and 36 others CompletedA Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular EdemaA two part, multi-center study consisting of a Phase 1b open label, sequential dose escalation followed by a Phase 2a randomized, double-masked, dose expansion evaluating OPT-302…NCT03397264·Phoenix, Arizona and 52 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

CompletedCombination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRxThis is for a randomized clinical trial (RCT) to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either…NCT00211887·Birmingham, Alabama and 70 others

TerminatedVesair Clinical TrialSingle-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment of Stress Urinary Incontinence in post-menopausal womenNCT04026347·Phoenix, Arizona and 24 others

TerminatedAndrogen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesNewly diagnosed metastatic prostate cancer subjects with bone metastases will be accrued to this stratified randomized 2-arm Phase II trial.NCT02582749·Phoenix, Arizona and 11 others

CompletedSafety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)The purpose of this study to evaluate the safety and immunogenicity of a 2-dose regimen of 9vHPV vaccine, where the first dose is administered concomitantly with a first dose of a…NCT05119855·Phoenix, Arizona and 37 others

CompletedA Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)A Phase 3 study to evaluate the efficacy and safety of two dosing regimens of telaprevir in combination with pegylated interferon alfa 2a (Peg-IFN-alfa-2a) and ribavirin (RBV).NCT00627926·Birmingham, Alabama and 115 others

TerminatedEfficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesThe purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), plus metformin compared to glimepiride plus metformin in participants with type 2…NCT01481116·Dothan, Alabama and 225 others

Active not recruitingThe Syn-Sleep StudyIn collaboration with approximately 8 centers that specialize in iRBD we will recruit a total of 80 individuals for the study.NCT05757206·Chandler, Arizona and 7 others

CompletedEffect of Ruboxistaurin on Clinically Significant Macular EdemaThe purpose of the study is to test the hypothesis that oral administration of ruboxistaurin will reduce the occurrence of sustained moderate visual loss (SMVL) in patients with…NCT00133952·Phoenix, Arizona and 40 others

Active not recruitingA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisThe purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.NCT06025578·Birmingham, Alabama and 458 others

RecruitingTransgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental DisordersThe study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.NCT04322734·Phoenix, Arizona and 1 other

CompletedA Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabThe purpose of this study is to assess the effect of nemolizumab (CD14152) on humoral immune responses to tetanus and meningococcal vaccination in adult and adolescent…NCT04365387·Phoenix, Arizona and 63 others

TerminatedBemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) and nivolumab.NCT05111626·Phoenix, Arizona and 347 others

CompletedAn Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act NowThe primary objective is to confirm the specificity of a multi-target stool DNA test (mt-sDNA), Cologuard, in an average risk population, ages 45-49.NCT03728348·Phoenix, Arizona and 38 others

TerminatedCarotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System with the Xact® Carotid Stent…NCT00106938·Phoenix, Arizona and 61 others

RecruitingA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular…NCT07662213·Birmingham, Alabama and 208 others

Active not recruitingASCEND CSP IDE StudyThis is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject…NCT06830746·Huntsville, Alabama and 36 others

CompletedStudy About Group and Phone Follow-Up After a CrisisCrisis stabilization centers (CSCs) provide a less costly and more comfortable alternative to Emergency Department care for individuals with suicidal crises.NCT05637203·Phoenix, Arizona and 1 other

PreviousPage 268 of 413Next

in Phoenix

Heart Diseasein Phoenix